Weekly updateCompaniesRecruiting servicePost a job
Foghorn Therapeutics

Foghorn Therapeutics

    Company info:

  • 101-250
  • 2016
  • Cambridge, MA
  • 100-500M


foghorntx.com

linkedin.com


Claim company profile

About company:

Foghorn Therapeutics’ Gene Traffic Control platform is designed to target and modulate the chromatin regulatory system. Components of the chromatin regulatory system are synthesized and used for proprietary assays to guide the discovery and optimization of drug targets. High throughput screening of candidate compounds is then used to discover drugs that modulate the chromatin regulatory system.

Foghorn currently has multiple therapeutics targeting cancer in Phase 1 clinical trials in addition to therapeutics targeting transcription factors and synthetic lethal targets, among others, in discovery stages. Phase 1 trials are currently enrolling for uveal melanoma, synovial sarcoma, acute myeloid leukemia, and myelodysplastic syndrome.

Jobs:

Claim company profile to post jobs directly on this page and this website.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com